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Abstract A class II type alcohol dehydrogenase from rat liver 
was characterized at the cDNA level after screening cDNA li- 
braries in combination with PCR amplification of the 5'-part. The 
open reading frame translates into a polypeptide of 376 amino 
acid residues, which show 73% positional identity to the human 
class II enzyme. This suggests that the class II enzyme is the most 
variable form of the mammalian alcohol dehydrogenases. A dele- 
tion is apparent corresponding to position 294 of the human 
enzyme and amino acid residues unique to the rat protein of those 
interacting with the coenzyme NAD ÷ are found at positions 47, 
51, 178, and 271. Position 47 is occupied by Pro instead of Arg 
or His found in most mammalian alcohol dehydrogenases. This 
exchanged residue will not hydrogen bond to the pyrophosphate 
of the coenzyme and will change the local environment around 
position 47 to strictly hydrophobic. 
Key words': Alcohol dehydrogenase; cDNA sequence; Amino 
acid substitution; Active site 
1. Introduction 
Rat is a widely used model species in studies of the metabo- 
lism and pharmacology of ethanol. Three distinct forms of rat 
alcohol dehydrogenase (ADH) have been defined by activity 
staining after starch gels electrophoresis, isolation [1], and 
structural characterization [2,3]. These three forms correspond 
to the ADHs of classes I, II I and IV [24]. The rat class IV 
ADH exhibits enzymatic haracteristics similar to some of 
those of class II [1], but so far the existence of a class II ADH 
in rat or other rodents has not been shown. 
Human class II ADH, with zr subunits, is relatively insensi- 
tive to inhibition by pyrazole [5], an effective inhibitor of class 
I ADH. Class II ADH shows higher Km and kca t values for 
ethanol than the class I isozymes [6]. It catalyzes the oxidation/ 
reduction of a broad range of alcohols/aldehydes with Km val- 
ues ranging from 7 pM (hydrophobic substrates) to about 0.5 
M (fairly hydrophilic substrates) [6,7]. The large variation in K m 
values for different substrates reflects the importance of hydro- 
phobic interactions in substrate binding. The primary structure 
has been determined for human class II ADH [8], which shows 
about 60% residue identity to those of the other classes of 
human ADH [9]. Other mammalian class II type ADHs have 
been isolated and characterized enzymatically from horse and 
monkey livers [10,11]. An ADH with class II type structural 
characteristics has also been isolated and characterized froli1 
ostrich liver [12]. 
This report describes the characterization f cDNA clones 
coding for a rat class II type enzyme, and defines the relation- 
ships to other mammalian ADHs. 
2. Materials and methods 
2.1. Screening of cDNA libraries 
Two rat liver cDNA libraries in )~gtl 1 with mRNA isolated from 
female and male rats, Y-extended and oligo(dT) plus random primed 
(Clontech Inc., CA), were screened with a 350 bp cDNA fragment 
coding for human class II ADH [8]. The fragment was nick-translated 
with [ct-32p]dCTP (Amersham, UK) and DNA polymerase/DNase (In- 
ternational Biotechnology Inc., CT) prior to screening the cDNA li- 
braries. Phage isolation was performed according to standard proce- 
dures [13]. cDNA inserts were size estimated by agarose gel electropho- 
resis after cleavage with EcoRI, were purified with glass beads (BIO 
101, CA) and were subcloned into pEMBL vectors. Restriction map- 
ping with endonucleases was performed, and selected fragments were 
further purified and subcloned into M13mpl8 or mp19 vectors. Plas- 
mids were purified with the Qiagen ion exchange procedure (Diagen, 
FRG). 
2.2. Generation of full-length cDNA 
mRNA was isolated from rat liver (1 g) with the guanidinium-thiocy- 
anate method and further purified on oligo-dT cellulose spin columns 
(Pharmacia Biotech, Sweden). One/ag mRNA was reverse transcribed 
with 2.5 U of avian myeloblastosis v rus reverse transcriptase (Boerhin- 
ger-Mannheim, FRG) using a 30-mer oligonucleotide primer (pl; Fig. 
1). The cDNA product obtained was purified on a Chroma-Spin 400 
column (Clontech Inc., CA) and residual mRNA was hydrolyzed with 
0.5 M NaOH. The single-stranded cDNA was ligated with an anchor 
27-mer oligonucleotide, harbouring an EcoRI restriction site, using T4 
RNA ligase (Amplifinder; Clontech Inc., CA). The cDNA obtained was 
PCR-amplified with Taq polymerase (AmpliTaq, Perkin-Elmer, CA) 
using a 5'-anchor primer (Clontech Inc., CA) complementary to the 
ligated 27-mer oligonucleotide, and a 3'-primer harbouring a HindIII 
restriction site (p2; Fig. 1). The protocol for PCR amplification used: 
35 cycles of 94°C, 45 s; 56°C, 45 s; 72°C, 1 min. The PCR product was 
size fractionated on 1.5% agarose gel, purified with glass beads and 
digested with EcoRI and HindIII before ligation into digested 
pBluescript vector. 
2.3. Sequence analysis 
DNA sequence analysis was carried out with T7 DNA polymerase 
(Pharmacia Biotech, Sweden) and [~-35S]dATP (Amersham, UK). The 
entire cDNA was determined by DNA sequence analysis on both 
strands and the PCR amplified Y-end was analyzed in two independ- 
ently cloned fragments. All sequences obtained were analyzed with the 
Wisconsin Package [13] and compared with the EMBL data bank. 
3. Results 
*Corresponding author. Fax: (46) (8) 338 453. 
Note: The novel nucleotide sequence data reported here have been 
submitted to the EMBL/GenBank Data Banks. 
3.1. Isolation of cDNA clones 
A total of 500,000 plaques derived from two independent rat 
liver cDNA libraries were screened with a cDNA fragment 
coding for human class II ADH. Ten faint positive signals were 
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1 GGAGCATTCT GGGTAGAGGT GAAAGGCCAG AGTCAGAAGG AAGAGTTCCA AAGCAAGCTT CCCAAGGAAA 
71 ATGGGCACCCAGGGAAAGGTCATTACATGCAAGGCAGCCATTGCCTGGAAAACTGACAGCCCCCTTTGCATTGAAGAA 
G lyThrG lnGlyLysVa l I leThrCysLysA laA la I leA laTrpLysThrAspSerProLeuCys I leG luGlu  
1 i0 20 
149 ATTGAAGTTTCTCCTCCTAAGGCTCATGAAGTTCGAATTAAGGTAATCGCCACATGCGTGTGCCCTACTGACATCAAT 
I leG luVa lSerProProLysA laH isG luVa lArg I leLysVa l I leA laThrCysVa lCysProThrAsp I leAsn  
30 40 50 
227 GCCACCAATCCTAAGAAGAAAGCTCTCTTCCCAGTAGTCCTCGGCCATGAGTGTGCAGGAATTGTAGAAAGCGTTGGG 
AlaThrAsnProLysLysLysAlaLeuPheProValValLeuGlyHisGluCysAlaGlyIleValGluSerValGly 
60 70 
. . . . . . . . . . .  p2 . . . . . . .  ~ ... .  ' . . . . . . . . . .  pl . . . . . . . . . . .  
305 CCAGGAGTGACCAACTTCAAACCAGGTGACAAAGTAATCCCATTCTTCGCACCACAGTGCAAAAAGTGCAAGCTCTGT 
ProGlyVa lThrAsnPheLysProGlyAspLysVa l I leProPhePheA laProGlnCysLysLysCysLysLeuCys  
80 9O 100 
383 CTGAGTCCTCTCACGAACCTCTGTGGGAAGCTCAGAAATTTTAAATACCCTACTATTGATCAAGAGCTCATGGAAGAC 
LeuSerProLeuThrAsnLeuCysGlyLysLeuArgAsnPheLysTyrProThr I leAspGlnGluLeuMetG luAsp  
110 120 
461 AGAACCAGCAGGTTTACCAGCAAAGAAAGATCAATTTACCACTTCATGGGAGTCAGTTCCTTCTCTCAGTACACTGTG 
ArgThrSerArgPheThrSerLysGluArgSer I leTyrH isPheMetG lyVa lSerSerPheSerG lnTyrThrVa l  
130 140 150 
539 GTTTCAGAAGCCAATCTTGCCCGAGTGGATGATGAGGCAAATTTGGAGAGAGTGTGTCTGATTGGATGTGGGTTCACA 
Va lSerG luA laAsnLeuA laArgVa lAspAspGluA laAsnLeuGluArgVa lCysLeu I leG lyCysGlyPheThr  
160 170 180 
617 TCAGGCTATGGGGCTGCGATCAACACTGCCAAGGTCACCCCTGGTTCCGCTTGTGCTGTCTTTGGCCTGGGGTGTGTA 
SerG lyTyrG lyA laA la I leAsnThrA laLysVa lThrProGlySerA laCysA laVa lPheGlyLeuGlyCysVa l  
190 200 
695 GGTCTTTCTGCTGTAATTGGATGTAAAATAGCAGGTGCTTCCAGAATCATAGCTATTGACATCAACAGTGAGAAGTTC 
G lyLeuSerA laVa l I leG lyCysLys I leA laG lyA laSerArg I le I leA la I leAsp I leAsnSerG luLysPhe  
210 220 230 
773 CCAAAAGCCAAGGCCCTGGGAGCCACTGACTGCCTTAATCCCAGAGACCTAGACAAACCTGTCCAAGATGTCATCACT 
ProLysA laLysA laLeuGlyA laThrAspCysLeuAsnProArgAspLeuAspLysProVa lG lnAspVa l I leThr  
240 250 
851 GAACTGACGGGTGGAGGTGTGGATTTCTCCCTGGACTGTGCAGGAACAGCTCAGACCTTGAAAGCAGCTGTAGACTGC 
G luLeuThrG lyG lyG lyVa lAspPheSerLeuAspCysA laG lyThrA laG lnThrLeuLysA laA laVa lAspCys  
260 270 280 
929 ACCGTCGTAGGCTGGGGGTCGTGCACTGTGGTCGGAGCAAAGGTTGATGAAATGAATATATCCACCGTGGACATGATA 
ThrVa lVa lG lyTrpGlySerCysThrVa lVa lG lyA laLysVa lAspGluMetAsn I leSerThrVa lAspMet I le  
290 300 310 
1007 TTGGGCCGTTCTGTAAAGGGAACGTTCTTTGGTGGTTGGAAAAGTGTAGACTCTGTCCCAAACCTGGTTACTGACTAC 
LeuGlyArgSerVa lLysG lyThrPhePheGlyGlyTrpLysSerVa lAspSerVa lProAsnLeuVa lThrAspTyr  
320 330 
1085 AAGAATAAGAAATTCGATCTGGACTTACTGGTGACCCATGCCCTACCTTTTGACAAAATCAACGACGCGATTGACCTG 
LysAsnLysLysPheAspLeuAspLeuLeuVa lThrH isA laLeuProPheAspLys I leAsnAspA la i leAspLeu  
340 350 360 
1163 ATGAACCAAGGAAAAAGCATCCGAACAATCCTGACCTTTTGA AGACGCCAGG AGGAACTTGG AATGTCATCA 
MetAsnGlnGlyLysSer I leArgThr I leLeuThrPhe  * 
370 
1235 GATTGGATCC AAGCTTGTCC AGATGACTTC CCACTTCCCA CGATGAGCCA AGGAAAGCG 
Fig. 1. Nucleotide and deduced amino acid sequences of rat class II type ADH. Nucleotides are numbered on th  left-hand side and amino acid residues 
below the sequence. The numbering used  the running text and in Table II corresponds to the system for class I ADH [19]. The rat class II enzyme 
has a four-residue insertion at position 120 and a two-residue deletion at position 294. Arrows above the sequence outline the primers used for reverse 
transcription (pl) and PCR amplification (p2). The arrow at nucleotide 232 indicates the 5'-end of the cDNAs isolated. 
obtained that gave strong signals after rescreening. The corre- 
sponding cDNA inserts were subcloned into pEMBL vectors. 
All cDNA clones harboured inserts of about 1100 bp and 
showed the same restriction pattern. One of the clones was 
subjected to DNA sequence analysis which resulted in a se- 
quence of 1065 bp including a 89 bp 3'-noncoding region. This 
does not correspond to a full-length cDNA. Partial DNA se- 
quence determination showed that all cDNAs are truncated at 
the same position. To obtain a full-length cDNA, a modified 
variant of rapid amplification ofcDNA ends was used (RACE; 
[15]), including an anchor oligonucleotide and T4 RNA ligase. 
This resulted in a 300 bp fragment hat was ligated into a 
pBluescript vector. The 300 bp fragment harboured the 5'-part 
of the cDNA and completed, together with the directly cloned 
cDNA the entire coding region. This generated a cDNA coding 
for a rat class II type ADH. The cDNA covers 1293 bp includ- 
ing the coding sequence of 1131 bp and a 5"-noncoding 70 bp 
segment (Fig. 1). The region around the ATG start codon 
shows large similarity to the human class II cDNA sequence 
and alignment of the whole cDNA sequence with that of the 
human class II enzyme reveals a positional identitiy of 79%. 
3.2. Deduced amino acid sequence 
The translated amino acid sequence results in a polypeptide 
chain of 376 amino acid residues (excluding the initiator Met 
presumably removed as in other ADHs [16]). Alignment of the 
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Table 1 
Positional identities between alcohol dehydrogenases T p: amino acid 
residue identities between human and r t ADHs. Bottom: residue iden- 
tities within the set of rat ADHs. Amino acid sequences and previously 
known positional identities from refs. [2,3,19,29] 
Human versus rat. 
class I class II class III class IV 
82% 73% 94% 87% 
Rat class II type versus rat classes I, II, and IV 
class I class III class IV 
55% 57% 52% 
rat amino acid sequence to other ADH sequences gives the 
highest identity to the human class II ADH, 73%, with two 
gaps. Comparisons of the other ADH classes from rat and 
human result in much higher values (Table 1). Within the set 
of rat ADHs, the class II type ADH shows positional identities 
with the other classes of 52% 57% (Table 1). 
The deduced amino acid sequence shows an insertion of four 
residues around position 120, also found in the human class II 
amino acid sequence. The rat enzyme has two deletions, one at 
position 60 and one at positions 294~295 as compared to the 
human class II ADH. The regions around these two deletions 
show very low homology to the human class II ADH and the 
positions for the deletions are somewhat tentative. Amino acid 
residues lining the active site pocket differ widely from the ones 
of human class II, and at some positions the rat enzyme shows 
residues not found in other ADHs. These residues are Lys 57 
(recently found also in a deer-mouse variant [17]) at the middle 
part of the active-site pocket and ga l  3°6 at the outer part of the 
pocket (Table 2A). Amino acid residues lining the coenzyme- 
binding pocket but not found at corresponding positions in 
other ADHs are Pro 47, Asn 51, Ser 178 and Thr 271 (Table 2B). 
4. Discussion 
A class II type ADH from rat was isolated at the cDNA level 
after screening liver cDNA libraries. To obtain the entire 
eDNA, PCR amplification of the Y-end was performed. The 
eDNA harbours an open reading frame of 1131 bp which trans- 
lates into 376 amino acid residues. An insertion of four amino 
acid residues around position 120 is identified, as compared to 
other ADH classes, which seems to be typical for class II ADH 
[8,12]. Furthermore, the rat ADH has a two-residue deletion 
around position 294, which has not been found in any mammal- 
ian ADH. However, in a fish ADH (cod) a deletion is found 
at position 295, but is compensated for by a large residue at 
position 294 [18]. The position of the deletion in the rat enzyme 
is not unambiguously defined because of the low homology 
between class II ADH and other ADHs in the region around 
position 294. Position 294 is occupied by Val in most character- 
ized mammalian ADHs and has been ascribed a structural 
function at the middle part of the active-site pocket [19]. In class 
I ADH, Va1294 is further involved in the conformational change 
associated with NAD ÷ binding and interacts with the nicoti- 
namide moiety [20]. 
The amino acid residues lining the active site pocket in the 
rat enzyme differ in many respects from corresponding residues 
in other mammalian ADHs (Table IA). This promotes changes 
Table 2 
Amino acid residues lining the substrate-binding cleft (A) and the coenzyme-binding cleft (B) in human and rat ADHs. The numbering corresponds 
to the system used for class I ADH [18]. Residues in italics are those determined in this report. A indicates a deletion. Data from r fs. [2,3,17,19,29,30] 
A. inner part of binding cleft middle and outhor part of binding cleft 
Position 48 93 140 141 57 110 115 116 294 306 318 
Human I ~ Thr Ala Phe Leu Met Tyr Asp Val Val Met Leu Ile 
Human 1,6 Thr Phe Phe Leu Leu Tyr Asp Leu Val Met Leu Val 
Human I )' Ser Phe Phe Val Leu Tyr Asp Leu Val Met Leu Ile 
Rat I Ser Phe Phe Leu Leu Tyr Asn Leu Val Met Leu Ile 
Human II Thr Tyr Phe Phe Phe Phe Set Ash Val Glu Ile Phe 
Rat H Thr Phe Phe Met Lys Leu Arg Asn A* Val Ile Phe 
Human III Thr Tyr Tyr Met Asp Leu Arg Val Val Phe Val Ala 
Rat III Thr Tyr Phe Met Asp Leu Arg Val Val Phe Val Ala 
Human IV Thr Phe Phe Met Met Leu Asp Ile Val Met Phe Val 
Rat IV Thr Phe Phe Met Met Leu Asp Leu Ala Met Phe Val 
Human V Thr Phe Phe Gly His Phe Lys Gln Val Gln Phe Val 
*The region around position 294 shows low homology between rat class II and the other ADHs which results in a somewhat tentative position for 
the deletion. 
B. 
Position 47 48 51 178 203 223 224 228 269 271 369 
Human I a Gly Thr His Thr Val Asp Ile Lys Ile Arg Arg 
Human I fla Arg Thr His Thr Val Asp Ile Lys Ile Arg Arg 
Human I )'b Arg Ser His Thr Val Asp Ile Lys Ile Arg Arg 
Rat I Arg Ser His Thr Val Asp Ile Lys Ile Arg Arg 
Human II His Thr Thr Thr Val Asp Ile Lys Ala Gly Arg 
Rat H Pro Thr Asn Ser Val Asp lle Lys Ala Thr Arg 
Human III His Thr Tyr Thr Val Asp Ile Lys Ile Asn Arg 
Rat III His Thr Tyr Thr Met Asp Ile Lys Ile Asn Arg 
Human IV Arg Thr His Thr Met Asp Leu Lys Ile His Arg 
Rat IV Gly Thr His Thr Met Asp Ile Lys Ile Arg Arg 
Human V Gly Thr His Thr Gly Asp Val Lys Ile Asn Arg 
aThe allelic variant •2 has His at position 47 and the allelic variant f13 has Cys at position 369. 
bThe allelic variant )'2has Gln at position 271. 
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in the shape of the active site pocket, first because of the dele- 
tion at position 294-295 (or in that loop region), and further 
because of the introduction of a proline residue at position 47. 
In most ADHs investigated, the latter position is occupied by 
Arg or His [19], residues that form hydrogen bonds to the 
pyrophosphate of the coenzyme [20,21]. In some ADHs, Gly 
occupies position 47 and this residue cannot yield hydrogen 
bonds to the pyrophosphate [9,21]. Two variants investigated, 
human class I e and rat class IV, show that Gly at position 47 
results in highly altered kinetic parameters [3,22]. The same will 
probably be true for Pro, which also is unable to hydrogen 
bond to NAD +. Moreover, the local environment around posi- 
tion 47 will also be changed by introduction of the strictly 
hydrophobic Pro. The rat class II type shows unique residues 
also at positions 51, 178, and 271, that likely will affect the 
coenzyme binding. The latter position, that of 271, differenti- 
ates the allelic )'1 and )'2 isozymes of human class I [23]. Fur- 
thermore, at the middle part of the substrate-binding pocket 
two positive charges are introduced as compared to the human 
enzyme. These are Arg 11s, typical for class III ADH (Table 2A; 
[2,9]), and Lys s7, elsewhere found in a deer-mouse ADH [17]. 
Finally, Val 3°6 is unique and probably will contribute to a 
slightly wider opening at the active-site pocket. 
The results obtained from the characterized cDNA show that 
class II ADH is the most variable type of the mammalian class 
I - IV enzymes. Class III ADH, the origin of the medium-chain 
alcohol dehydrogenases, thus constitutes the far most con- 
served structure [9], and class II is shown to be another extreme 
with only 73% positional identity (Table I, cf. ref. [24]). The 
meaning of the large structural variance of the class II enzymes 
is not known, but in contrast o class III ADH/glutathione- 
dependent formaldehyde dehydrogenase [25], the function 
seems not to be strictly specific. The human class II enzyme can 
catalyze the conversion of a broad range of alcohols and alde- 
hydes [5,6] including 4-hydroxyalkenals [7]and retinoic com- 
pounds [26]. Human class II ADH has been shown to be the 
best hepatic ADH in retinol/retinal metabolism, while class IV 
ADH has been shown to be the enzyme with corresponding 
properties in epithelial tissues [26]. The rat class II type now 
characterized has identical amino acid residues lining the inner 
part of the active-site pocket as class IV (Table 2A), and prob- 
ably can catalyze the oxidation of retinol. 
A class II ADH has never been observed in a rat organ at 
the protein level [1,27], but Northern blot analysis hows that 
mRNA coding for a rat class II type ADH is clearly present in 
liver, duodenum, kidney, stomach, and testis [28]. The rat class 
II type ADH can have a shifted substrate specificity as com- 
pared to other characterized mammalian ADHs and thereby 
not have been detected in the screening methods used. Class II 
type ADHs have been shown to be present in primates, horse 
and in ostrich [5,10 12], but rodents have not a class II ADH 
protein that has retained the structural and activity characteris- 
tics of the human enzyme. 
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